Outcome

This study examined how different pressures of hyperbaric oxygen therapy (HBOT) affect the expression of inflammatory genes in human endothelial cells. It was found that a lower pressure of 1.5 atmospheres absolute (atm abs) led to more significant changes in gene expression compared to a higher pressure of 2.4 atm abs.

Introduction

This study examined how different pressures of hyperbaric oxygen therapy (HBOT) affect the expression of inflammatory genes in human endothelial cells. Researchers found that a lower pressure of 1.5 atmospheres absolute (atm abs) led to more significant changes in gene expression compared to a higher pressure of 2.4 atm abs. The study highlighted the need to optimize therapeutic protocols as different pressures had varied effects on genes related to adhesion angiogenesis tissue remodeling intracellular signaling and oxygen response.

Results

The study investigated the impact of different hyperbaric oxygen therapy (HBOT) pressures on the expression of inflammatory genes in human endothelial cells. Specifically it assessed the effects of normobaric oxygen (1.0 atmospheres absolute atm abs) low pressure HBOT (1.5 atm abs) and higher pressure HBOT (2.4 atm abs) on the mRNA expression profiles of 92 inflammatory genes. The human endothelial cells were exposed to a single 90-minute treatment and gene expression changes were monitored at 5 hours and 22.5 hours post-treatment.

Significant gene expression changes were noted particularly at the 5-hour mark indicating an acute response to oxygen treatment. Lower pressure HBOT at 1.5 atm abs induced more pronounced changes across a spectrum of genes related to crucial processes like adhesion molecule expression angiogenesis tissue remodeling intracellular signaling cellular oxygen response and redox signaling compared to the 2.4 atm abs treatment.

These findings run counter to the common belief that higher oxygen pressures invariably enhance therapeutic efficacy. The enhanced gene expression at 1.5 atm abs suggests a more effective modulation of inflammatory pathways which is pivotal for therapeutic applications in chronic wound care and other inflammatory conditions.

At the 22.5-hour mark most of the initial changes in gene expression had diminished indicating the transient nature of the transcriptional response to oxygen treatment. This underscores the importance of treatment timing and suggests that multiple or sustained treatments may be required to maintain therapeutic effects.

In conclusion the study demonstrates that moderate hyperbaric oxygen pressures (1.5 atm abs) are potentially more effective than higher pressures (2.4 atm abs) in modulating inflammatory gene expression in human endothelial cells. These results highlight the necessity of optimizing HBOT protocols to maximize clinical benefits particularly for managing chronic wounds and inflammatory diseases.

Conclusion

In conclusion this study highlights the varying impacts of hyperbaric oxygen therapy (HBOT) pressures on inflammatory gene expression in human endothelial cells. Significantly the findings reveal that a lower pressure of 1.5 atmospheres absolute (atm abs) induces more pronounced changes in gene expression than a higher pressure of 2.4 atm abs. This suggests that moderate HBOT pressures may be more efficacious in modulating key inflammatory pathways involved in adhesion angiogenesis tissue remodeling and cellular oxygen responses. These insights crucially emphasize the need to optimize HBOT protocols specifically tailoring pressure levels to maximize therapeutic outcomes for chronic inflammatory conditions and wound care. Future research should continue to explore the nuanced effects of different HBOT pressures aiming to refine and enhance therapeutic strategies to benefit patients with various medical conditions.